It has been really hard finding anything to buy. In an attempt to increase my pharma exposure I bought an entry position in AbbVie Inc. in the from of 20 shares bought for 107,99 USD per share. Let’s consider this as a maintenance purchase while waiting for better market conditions. Good enough company in good enough position with good enough valuation. Good enough in these markets.